Epigral Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 4,781.46 million compared to INR 5,555.31 million a year ago. Revenue was INR 4,791.5 million compared to INR 5,572.07 million a year ago. Net income was INR 379.96 million compared to INR 915.69 million a year ago. Basic earnings per share from continuing operations was INR 9.14 compared to INR 22.04 a year ago. Diluted earnings per share from continuing operations was INR 9.14 compared to INR 22.04 a year ago.
For the six months, sales was INR 9,330.39 million compared to INR 10,883.8 million a year ago. Revenue was INR 9,355.67 million compared to INR 10,920.87 million a year ago. Net income was INR 695.03 million compared to INR 1,993.62 million a year ago. Basic earnings per share from continuing operations was INR 16.73 compared to INR 47.98 a year ago. Diluted earnings per share from continuing operations was INR 16.73 compared to INR 47.98 a year ago.